| Trial to Evaluate the Safety and Effectiveness of Treatment With COMS One Device in Subjects With Diabetic Foot Ulcers | N/A | Piomic Medical | <1 mi |
| Matrion Decellularized Placental Membrane Versus Conventional Wound Management in Subjects With Diabetic Foot Ulcers | N/A | LifeNet Health | <1 mi |
| A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes | Phase 3 | Novo Nordisk A/S | <1 mi |
| Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD) | Phase 2/3 | CSL Behring | <1 mi |
| Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot Ulcers | N/A | Tides Medical | <1 mi |
| Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D) | Phase 2 | Sparrow Pharmaceuticals | <1 mi |
| A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes | Phase 3 | Eli Lilly and Company | <1 mi |
| A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes | Phase 2 | Novo Nordisk A/S | <1 mi |
| A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus | Phase 3 | AstraZeneca | <1 mi |
| Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease | Phase 3 | Prokidney | <1 mi |
| A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin | Phase 3 | Eli Lilly and Company | <1 mi |
| A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes | Phase 3 | Eli Lilly and Company | <1 mi |
| A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM | Phase 3 | AstraZeneca | <1 mi |
| Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes | N/A | Endogenex, Inc. | <1 mi |
| Evaluating a Lifestyle Intervention to Prevent Recurrence of Diabetic Foot Ulcers | N/A | University of Southern California | <1 mi |
| Smart Boot Use to Measure Offloading Adherence | Phase 2 | University of Southern California | <1 mi |
| A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes | Phase 3 | Sanofi | <1 mi |
| Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes | N/A | Insulet Corporation | <1 mi |
| A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma | Phase 2 | Children's Oncology Group | <1 mi |
| TrialNet Pathway to Prevention of T1D | — | University of South Florida | <1 mi |
| Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease | Phase 2 | Pharming Technologies B.V. | <1 mi |
| Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT) | — | M.D. Anderson Cancer Center | <1 mi |
| PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes | Phase 4 | Brigham and Women's Hospital | <1 mi |
| Automated Insulin for Management of Intrapartum Glycemia | N/A | University of California, San Francisco | <1 mi |
| Time Limited Eating in Adolescents With Type 2 Diabetes (KT2D) | N/A | Children's Hospital Los Angeles | <1 mi |
| A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes | Phase 2 | Zucara Therapeutics Inc. | <1 mi |
| Type 2 Diabetes and Blood Brain Barrier Improvement | Early 1 | University of California, Los Angeles | <1 mi |
| DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes | Phase 4 | Ohio State University | <1 mi |
| Diabetes RElated to Acute Pancreatitis and Its Mechanisms | — | Milton S. Hershey Medical Center | <1 mi |
| Feasibility of a Nutrition Intervention for Patients With Prediabetes at a Federally Qualified Health Center | N/A | Cedars-Sinai Medical Center | <1 mi |
| DISCOVERY of Risk Factors for Type 2 Diabetes in Youth | — | George Washington University | <1 mi |
| Study of WAL0921 in Patients With Glomerular Kidney Diseases | Phase 2 | Walden Biosciences | <1 mi |
| INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes | Phase 2 | Mannkind Corporation | <1 mi |
| Diabetes RElated to Acute Pancreatitis and Its Mechanisms: Metabolic Outcomes Using Novel CGM Metrics | — | Milton S. Hershey Medical Center | <1 mi |
| New T-UP: Engaging Vulnerable Students in Diabetes Prevention | N/A | University of California, Los Angeles | <1 mi |
| CGM Academy for Youth With Type 1 Diabetes | N/A | Children's Hospital Los Angeles | <1 mi |
| Registry for Stage 2 Type 1 Diabetes | — | Sanofi | <1 mi |
| Implementation of Team Clinic for Type 2 Diabetes (TCT2) | N/A | Children's Hospital Los Angeles | <1 mi |
| Adapting Lifestyle Offloading for DFUs | N/A | University of Southern California | <1 mi |
| DFC 004 Biomarkers for Active Diabetic Foot Ulcers | — | University of Michigan | <1 mi |
| Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM) | — | Jaeb Center for Health Research | <1 mi |
| A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS) | Phase 3 | Eli Lilly and Company | <1 mi |
| Transformative Research in Diabetic Nephropathy | — | University of Pennsylvania | <1 mi |
| DETERMINE: Detemir vs NPH | Phase 2 | University of California, Los Angeles | <1 mi |
| A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing. | N/A | Molnlycke Health Care AB | <1 mi |
| Type 2 Continuous Glucose Monitoring Academy | N/A | Children's Hospital Los Angeles | <1 mi |
| Postpartum Continuous Glucose Monitoring for Type 2 Diabetes Mellitus Risk Evaluation in Patients With Gestational Diabetes Mellitus: POSTPOD Trial | N/A | University of California, Los Angeles | <1 mi |
| This Study is to Evaluate Whether Receiving Education and Glucose Monitoring With the CGM Device Will Improve Patient-reported Outcomes by Improving Patient's Satisfaction and Quality of Life (QOL) With Glucose Monitoring Device | — | Cedars-Sinai Medical Center | <1 mi |
| Continuous Glucose Monitoring (CGM) in Prediabetes With Community Based Recruitment | N/A | David S Black, PhD | <1 mi |
| Extended Oral Antibiotic Prophylaxis in Diabetic Fracture Patients | Phase 4 | Texas Tech University Health Sciences Center, El Paso | <1 mi |
| Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System | N/A | Insulet Corporation | <1 mi |
| A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus | Phase 3 | AstraZeneca | <1 mi |
| Study EHR Risk Stratification Tools | N/A | University of California, Los Angeles | <1 mi |
| A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity | Phase 3 | Pfizer | <1 mi |
| A Study of GNTI-122 in Adults Recently Diagnosed With T1D | Phase 1 | GentiBio, Inc | <1 mi |
| A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes | Phase 3 | Vertex Pharmaceuticals Incorporated | <1 mi |
| Metabolic Responses to Bariatric Surgery | — | University of California, Davis | <1 mi |
| Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD | Phase 2 | University of California, Davis | <1 mi |
| Use of CGM in Kidney Transplant Recipients | N/A | University of California, Davis | <1 mi |
| Randomized Trial of Supplemental Synchronous and Asynchronous Telehealth to Improve Glycemic Control for Pediatric Patients With Type 1 Diabetes | N/A | University of California, Davis | <1 mi |
| GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes | N/A | Medtronic MiniMed, Inc. | <1 mi |
| Pregnancy and Postpartum Breastfeeding Support for Patients With Gestational Diabetes | — | University of California, Davis | <1 mi |
| MiniMed Fit Payload Wear Pediatric Study | — | Medtronic MiniMed, Inc. | <1 mi |
| A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin | Phase 3 | AstraZeneca | <1 mi |
| Clinical Utility of an Amniotic Membrane Allograft for Diabetic Foot Ulcer Wound Management | N/A | Legacy Medical Consultants | <1 mi |
| SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes | Phase 2 | SAb Biotherapeutics, Inc. | <1 mi |
| Inflammation, Diabetes, Ethnicity and Obesity Cohort | — | University of California, San Francisco | <1 mi |
| Commercial or Open Source Closed Loop Impact on Pregnancy Study | — | University of California, San Francisco | <1 mi |
| A Longitudinal, Observational Study Comparing Real-World Experiences of Teplizumab-Treated and Untreated Participants With Stage 2 Type 1 Diabetes in the United States | — | Sanofi | <1 mi |
| Precision Dosing of Metformin in Youth With T2D | Early 1 | University of California, San Francisco | <1 mi |
| CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial | Phase 2 | Jason Sperry | <1 mi |
| HLA Demographics Study in Adults With Type 1 Diabetes | — | GentiBio, Inc | <1 mi |
| Village-Integrated Eye Worker Trial II | N/A | University of California, San Francisco | <1 mi |
| Achieving Chronic Care equiTy by leVeraging the Telehealth Ecosystem | N/A | University of California, San Francisco | <1 mi |
| Type 1 Diabetes Extension Study | — | National Institute of Allergy and Infectious Diseases (NIAID) | <1 mi |
| A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes | Phase 1/2 | City of Hope Medical Center | <1 mi |
| Strategies for Improving Linkage-to-Care After Eye Disease Screening | N/A | University of California, San Francisco | <1 mi |
| A Prospective Clinical Study to Evaluate the Effectiveness and Safety of Xcell Amnio MatrixTM (XAM) in the Management of Chronic Non-healing DFUs | N/A | New Horizon Medical Solutions | <1 mi |
| EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease | Phase 3 | Boehringer Ingelheim | <1 mi |
| Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes | Phase 4 | VA Office of Research and Development | <1 mi |
| Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy | Phase 2 | Biomea Fusion Inc. | <1 mi |
| Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Who Are Not Achieving Glycemic Targets | Phase 2 | Biomea Fusion Inc. | <1 mi |
| A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes | Phase 2 | Novo Nordisk A/S | <1 mi |
| A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus | Phase 3 | AstraZeneca | <1 mi |
| A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight | Phase 3 | Novo Nordisk A/S | <1 mi |
| Enhancing Digitally Delivered Diabetes Education With Real-Time CGM | N/A | Scripps Whittier Diabetes Institute | <1 mi |
| CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D) | Phase 1/2 | COUR Pharmaceutical Development Company, Inc. | <1 mi |
| More Fresh Fruit and Vegetable Prescription Program for Families With Type 2 Diabetes Mellitus | N/A | University of California, San Diego | <1 mi |
| Dulce Digital 2.0 - Innovative Diabetes Self-Management in the Digital Age | N/A | Scripps Whittier Diabetes Institute | <1 mi |
| Efficacy of Using Mobile Health Applications for Health | N/A | San Diego State University | <1 mi |
| Implementing Food Referrals for Equity and Sustained Health | Phase 2 | University of California, San Diego | <1 mi |
| ACT1VATE: Addressing Emotional Distress to Improve Outcomes Among Diverse Adults With Type 1 Diabetes | Phase 2 | Scripps Whittier Diabetes Institute | <1 mi |
| North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC) | — | Columbia University | <1 mi |
| Efficacy of mHealth Apps for Health in a Low-income, Type II Diabetic, Hispanic Population | N/A | San Diego State University | <1 mi |
| Continuous Glucose Monitoring for Self-Management of Type 2 Diabetes in Young Adults | N/A | San Diego State University | <1 mi |
| CGM for Management of Type 2 Diabetes in Pregnancy | N/A | University of Alabama at Birmingham | <1 mi |
| A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes | Phase 3 | Hoffmann-La Roche | <1 mi |
| CAMPR-II RWE TRIAL: A Saline-hydrated Allogeneic Dual-layer Amniotic Membrane Product or a Synthetic, Resorbable Polymeric Wound Matrix to a Coarsened Exact Matched Retrospective Control Cohort of Hard to Heal DFUs and VLUs | N/A | Capsicure, LLC | <1 mi |
| A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events | N/A | Cleerly, Inc. | <1 mi |
| Immediate Postpartum Glucose Tolerance Testing | — | MemorialCare Health System | <1 mi |
| A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes | Phase 3 | Hoffmann-La Roche | <1 mi |
| A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus | Phase 2 | Corxel Pharmaceuticals | <1 mi |
| Safer Aging With Diabetes Monitoring | N/A | Kaiser Permanente | <1 mi |
| A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight | Phase 2 | Eli Lilly and Company | 5 mi |
| A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional Cohort | Phase 1 | AstraZeneca | 6 mi |
| A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of RO7663498 Following Intravitreal Administration in Participants With Diabetic Retinopathy | Phase 1 | Hoffmann-La Roche | 6 mi |
| Safety and Drug Concentrations of REGN20934 in Adults With Overweight or Obesity | Phase 1 | Regeneron Pharmaceuticals | 6 mi |
| A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants | Phase 1 | AstraZeneca | 6 mi |
| A Clinical Trial of MK-1403 in Participants With Type 2 Diabetes Mellitus (MK-1403-006) | Phase 1 | Merck Sharp & Dohme LLC | 7 mi |
| A Single Bolus, 12-hour Euglycemic Clamp Study of the Safety, Pharmacokinetics (PK) and Glucodynamics (GD) of Intraperitoneal (IP) Portal Insulin U-500 | Phase 1 | Portal Diabetes, Inc. | 7 mi |
| Latinos Understanding the Need for Adherence in Diabetes Using E-Health | N/A | San Diego State University | 7 mi |
| A Study to Evaluate ALN-4324 on Insulin Sensitivity in Adults With Type 2 Diabetes Mellitus | Phase 2 | Alnylam Pharmaceuticals | 7 mi |
| A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Orally Administered TIX100 in Healthy Subjects | Phase 1 | TIXiMED, Inc. | 7 mi |
| AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight | Phase 3 | Novo Nordisk A/S | 7 mi |
| Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema | Phase 2/3 | AbbVie | 9 mi |
| Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions | Phase 1/2 | Thomas Advanced Medical LLC | 9 mi |
| A Study to Evaluate the Efficacy and Safety of Orally Administered VX-01 | Phase 2 | Vantage Biosciences Ltd | 9 mi |
| A Study of MET233 in Combination With MET097 in Individuals With Obesity or Overweight With or Without Diabetes | Phase 1/2 | Pfizer | 10 mi |
| Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes | Phase 3 | Kailera | 10 mi |
| Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes | Phase 3 | Kailera | 10 mi |
| Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCT | Phase 4 | Matthew J. Budoff | 10 mi |
| Starting Technology in At Risk Type 1 Diabetes Study | N/A | University of California, Los Angeles | 10 mi |
| Effect of Amnio-Maxx on the Healing Rate of Chronic Diabetic Foot Ulcers. | Phase 4 | Royal Biologics | 10 mi |
| THC Effects on Glucose in Type 2 Diabetes | Phase 1 | University of California, San Diego | 11 mi |
| Closed Loop and Education for Hypoglycemia Awareness Restoration | N/A | Milton S. Hershey Medical Center | 11 mi |
| Long Term Impact of Time-Restricted Eating on Parameters of Cardiometabolic Health | Phase 2 | University of California, San Diego | 11 mi |
| Acetazolamide in Persons With Type 1 Diabetes - Crossover Trial | Phase 2 | University of California, San Diego | 11 mi |
| Behavioral Approach for Latinas Addressing Nutrition, Cravings, and Eating Patterns to Prevent Type 2 Diabetes | N/A | University of California, San Diego | 11 mi |
| A Study to Evaluate the Effect of Obicetrapib/Ezetimibe 10 mg Fixed-Dose Combination or Obicetrapib 10 mg Daily on Top of Guideline-Recommended Lipid-Lowering Therapy in Participants With Type 2 Diabetes and/or Metabolic Syndrome | Phase 3 | NewAmsterdam Pharma | 11 mi |
| Time Restricted Eating in Patients With Microalbuminuria | Phase 1 | University of California, San Diego | 11 mi |
| Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer | — | Helio Genomics | 12 mi |
| Project Dulce for Arab Americans With Type 2 Diabetes | N/A | Scripps Whittier Diabetes Institute | 13 mi |
| Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease | Phase 2 | Regeneron Pharmaceuticals | 14 mi |
| Diabetes-Centered Evaluation of Revascularization Strategy of Functional and Imaging-CombiNEd State-of-the-Art Percutaneous Coronary Intervention or Coronary-Artery Bypass Grafting in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease | N/A | Duk-Woo Park, MD | 16 mi |
| Single-site Pilot Study Evaluating the Effect of QLS-111 Ophthalmic Solution on Posterior Perfusion and Vessel Dilation | Phase 2 | Qlaris Bio, Inc. | 16 mi |
| CHIME: Comparing Health Interventions for Maternal Equity | N/A | Stanford University | 16 mi |
| Food Insecurity Reduction & Strategy Team | N/A | Stanford University | 16 mi |
| Normal-weight Diabetes: Adipocyte-directed Therapy With Pioglitazone or Tirzepatide | Phase 4 | Stanford University | 16 mi |
| Circulating Biomarkers in the Development of Type 1 Diabetes | — | City of Hope Medical Center | 16 mi |
| Improving Islet Transplantation Outcomes With Gastrin for Type I Diabetes | Phase 1/2 | City of Hope Medical Center | 16 mi |
| Denosumab for Type 1 Diabetes | Phase 1/2 | City of Hope Medical Center | 16 mi |
| Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease | Phase 3 | Alessandro Doria | 17 mi |
| Post Prandial Individual Responses to Different Foods | N/A | Stanford University | 17 mi |
| Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance | N/A | Stanford University | 17 mi |
| SPYRAL GEMINI Pilot Study | N/A | Medtronic Vascular | 17 mi |
| Using Continuous Glucose Monitoring to Quantify the Effects of NOURISH's Culturally Modified Meals on Asian Americans With Type 2 Diabetes | N/A | Stanford University | 17 mi |
| Implementing Scalable, PAtient-centered, Team-based, Technology-enabled Care for Adults With Type 2 Diabetes (iPATH) | N/A | Stanford University | 17 mi |
| A Study to Assess the Efficacy, Safety and Tolerability of AT673 Co-administered With Semaglutide in Adult Participants With Type 2 Diabetes (T2D) and Overweight or Obesity | Phase 2 | Antag Therapeutics | 17 mi |
| High Dose Aflibercept in Diabetic Macular Edema in Patients With Previous Vitrectomy | Phase 4 | Retina Consultants of Orange County | 17 mi |
| A U.S. Pilot Human Investigation of RadiofrEquency Vapor Ablation System to Evaluate Safety, TOleRability, and Effectiveness for Proximal Intestinal Mucosal Ablation in Patients With Type 2 Diabetes Mellitus (RESTORE-1 Study) | N/A | Aqua Medical, Inc. | 19 mi |
| Safety and Efficacy of Adjunct Therapies in Adults With Type 1 Diabetes: Multicenter, Registry Study | — | Indiana University | 19 mi |
| A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide | Phase 2 | Eli Lilly and Company | 19 mi |
| EDX110 Randomized Control Trial for Treatment of DFUs | N/A | ConvaTec Inc. | 19 mi |
| Efficacy and Safety of Oral KAI-7535 in Adult Participants Living With Obesity or Overweight With at Least 1 Weight-Related Comorbidity | Phase 2 | Kailera | 21 mi |
| Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes | Phase 3 | Kailera | 21 mi |
| Accuracy and Precision of the Continuous Glucose Monitoring System 'CareSens Air 3' in Adult Patients With T1DM | N/A | i-SENS, Inc. | 21 mi |
| ROME GS System Study | N/A | Senseonics, Inc. | 21 mi |
| Dementia and Diabetes Prevention Program | N/A | University of California, Davis | 21 mi |
| Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes Mellitus | Phase 2 | Op-T LLC | 21 mi |
| HOPE Intervention for Fitness | N/A | University of California, Irvine | 22 mi |
| The iLet Experience Study | — | Beta Bionics, Inc. | 22 mi |
| HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes | Phase 2 | Housey Healthcare ULC | 23 mi |
| A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies | — | AstraZeneca | 24 mi |
| A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease | Phase 2 | Novo Nordisk A/S | 24 mi |
| Addressing Diabetes by Elevating Access to Nutrition | N/A | Stanford University | 25 mi |
| Gemini Study: A Prospective, Multicenter Evaluation of Performance and Safety of the Eversense Gemini System With Flash Glucose Measurement Feature | N/A | Senseonics, Inc. | 28 mi |
| A Trial Evaluating AMG 127 in Healthy Participants and Participants With Type 2 Diabetes Mellitus | Phase 1 | Amgen | 30 mi |
| Study Assessing Complete Wound Healing by Comparing Surgenex® PelloGraft in Treating DFU and SanoGraft® in Treating VLU to SOC | N/A | Surgenex | 34 mi |
| Dehydrated Human Amnion Membrane and Standard of Care Versus Standard of Care Alone in Nonhealing Diabetic Foot Ulcers | N/A | Axolotl Biologix | 35 mi |
| Nonhealing Diabetic Foot Ulcers Treated With Standard of Care (SOC) Alone or Standard of Care and Amnion-Intermediate-Chorion (AIC) | Phase 4 | Cellution Biologics | 49 mi |